Form 4: Phibro Animal Health Corp Director E. Thomas Corcoran Reports Transaction

E. Thomas Corcoran, a director at Phibro Animal Health Corp, reports purchasing 5,000 shares of Class A Common Stock at an average price of $22.1 and disposing of 30,000 shares on February 24, 2025.

Summary

• On February 24, 2025, E. Thomas Corcoran, a director of Phibro Animal Health Corp, purchased 5,000 shares of Class A Common Stock.
• The purchase price ranged from $22.02 to $22.11, with a weighted average price of $22.1.
• Corcoran also disposed of 30,000 shares.
• Following these transactions, Corcoran still beneficially owns securities of Phibro Animal Health Corp.

Sentiment

Score: 5

Explanation: This is a neutral report of a director's stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the buying and selling activities of company directors. It allows investors to monitor the confidence level of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice and are required by the SEC for company insiders.
• Similar filings can be observed for directors and officers of comparable companies in the animal health industry, such as Zoetis (ZTS) and Elanco Animal Health (ELAN).

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects insider trading activity, which can influence investor sentiment.

Key Dates